Search results

Part of the reason the cost is so low for genotyping is probably due to the push to keep the data in the public domain. I see a lot of patents and company's getting rich off the rest of the things you listed. And, as those patents expire, new ones are created with minor differences. Many...

much of that improvement will come at a higher cost. I can't imagine stem cell technologies coming cheep for instance. I'm banking on about the same. Health care costs up, everyday costs down.